INHIBIKASE THERAPEUTICS INC

Watch

Share

IKT·45719W205·US·Common Stock·Healthcare - Biotechnology-13D/G

IKT (INHIBIKASE THERAPEUTICS INC) is held by 67 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($15.8M), Blackstone Inc. ($12.1M), VANGUARD CAPITAL MANAGEMENT LLC ($10M). Net institutional sentiment: Bullish.

67

Holders

(5 Elite)

$71.1M

Total Value

68% (68)

Consensus

46 buying - 22 selling

13F: Jun 30, 2026Insider & Congress: Updated regularly

Smart Money Verdict

View all

Loading verdict

Institutional (13F)78

Insider (Form 4)38

Activist (13D/13G)35

Congressional (STOCK Act)61

Holder Quality

55

★★★★★

Elite

87

★★★★

Strong

63

★★★

Solid

21

★★

Below

56

★

Weak

Held by 67 funds

5 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Nov 24, 2025 · Activists Aug 14, 2026 · Congress none

ActivistPAPerceptive Advisors LLC6.9%Aug 14, 2026

ActivistNANantahala Capital Management, LLC4.3%Aug 14, 2026

ActivistSLSands Capital Life Sciences Pulse Fund II, L.P.9.3%Aug 13, 2026

Checking access…

View all insider tradesView all activist filings

Top Holders

Top Holders (67)History

AllNewIncreasedHeldDecreasedExited

Checking access…

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
BlackRock, Inc.	Increased	7.8M(+23.2%)	$15.8M	0.0%	+31.52%	34
Blackstone Inc.	Unchanged	5.9M	$12.1M	0.0%	+4.65%	0
VAVANGUARD CAPITAL MANAGEMENT LLC	Increased	4.9M(+10.9%)	$10M	0.0%	+29.57%	31
MILLENNIUM MANAGEMENT LLC	Increased	4M(+37.6%)	$8.2M	0.0%	+28.00%	36
GEODE CAPITAL MANAGEMENT, LLC	Increased	2.6M(+20.1%)	$5.3M	0.0%	+23.57%	32
STATE STREET CORP	Increased	1.9M(+13.2%)	$3.9M	0.0%	+33.28%	30
NORTHERN TRUST CORP	Increased	878,585(+22.2%)	$1.8M	0.0%	+29.53%	31
VPVANGUARD PORTFOLIO MANAGEMENT LLC	Increased	809,490(+31.0%)	$1.6M	0.0%	+28.46%	33
TWO SIGMA INVESTMENTS, LP	Decreased	806,264(-4.9%)	$1.6M	0.0%	+30.37%	0
VFVANGUARD FIDUCIARY TRUST CO	Increased	607,260(+7.1%)	$1.2M	0.0%	+29.82%	27
Pathstone Holdings, LLC	New	510,596	$1M	0.0%	+22.66%	35
AQR CAPITAL MANAGEMENT LLC	Increased	468,197(+172.2%)	$950,440	0.0%	+25.38%	40
Nuveen, LLC	Decreased	425,492(-9.9%)	$863,749	0.0%	+33.75%	0
Bank of New York Mellon Corp	Increased	303,126(+42.2%)	$615,346	0.0%	+37.40%	33
JPMORGAN CHASE & CO	Decreased	316,574(-3.6%)	$610,988	0.0%	+32.22%	0
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	Increased	275,041(+16.8%)	$558,333	0.0%	+40.94%	28
UBS Group AG	Decreased	204,654(-10.3%)	$415,448	0.0%	+32.19%	0
BLAIR WILLIAM & CO/IL	Decreased	156,080(-1.2%)	$316,842	0.0%	-10.02%	0
ALPS ADVISORS INC	New	134,002	$272,024	0.0%	+22.66%	32
DEUTSCHE BANK AG\	Increased	126,677(+3.5%)	$257,154	0.0%	+42.34%	24

Showing 1-20 of 73

Per page:

1 / 4

IKTINHIBIKASE THERAPEUTICS INC

1M3M6M1Y3Y5Y

Continue exploring

Smart money flow

Track where institutional capital is flowing

Discover new institutional entries

Fresh positions initiated this quarter

Check sector trends

Capital flows across GICS sectors

Other Healthcare stocks held by institutions

LLYELI LILLY & CO

403 holders · $856.6B

UNHUNITEDHEALTH GROUP INC

403 holders · $286.8B

TMOTHERMO FISHER SCIENTIFIC INC

388 holders · $148B

JNJJOHNSON & JOHNSON

385 holders · $405.5B

DHRDANAHER CORP

384 holders · $95B

ISRGINTUITIVE SURGICAL INC

381 holders · $105.8B

MRKMERCK & CO. INC.

378 holders · $226B

BSXBOSTON SCIENTIFIC CORP

375 holders · $51.2B

ABBVABBVIE INC

373 holders · $296.3B

ABTABBOTT LABORATORIES

371 holders · $110.7B

High Conviction Moves-Smart Money Convergence-Fund Consensus-Double-Down Detection

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer